Innogenetics renews therapeutic research collaboration with Solvay Pharmaceuticals
Solvay Pharmaceuticals and Innogenetics announced the renewal of their research collaboration intended to provide Solvay's drug development program with possible new candidate drug targets.
30-Jan-2003 -
For the last 5 years, Solvay and Innogenetics have successfully been involved in the identification of drug targets to enhance Solvay's drug development pipeline. This collaboration will now continue for a period of 3 years, extendable according to the projects' objectives and outcomes. During ...
drug development
molecular biology
research collaborations
+2